Search Within

Population Sciences Research Program

  1. "Meeting abstract"
Formats
  1. Meeting Abstract (3096)
Groups
  1. Department of Medicine (1690)
  2. Survivorship Research (1616)
  3. Epidemiology and Biostatistics (1119)
  4. Solid Tumor Oncology Division (1102)
  5. Psychiatry and Behavioral Sciences, Department of (788)
  6. Surgery (753)

More Groups

People
  1. Steven Horwitz (346)
  2. Mark Robson (248)
  3. Kenneth Offit (210)
  4. Christian Nelson (181)
  5. Katherine Panageas (168)
  6. Zsofia Stadler (147)

More People

Years
  1. 2024 (24)
  2. 2023 (251)
  3. 2022 (221)
  4. 2021 (206)
  5. 2020 (222)
  6. 2019 (242)

More Years

Publications
  1. Journal of Clinical Oncology (812)
  2. Blood (302)
  3. Annals of Behavioral Medicine (221)
  4. Psycho-Oncology (208)
  5. Cancer Research (189)
  6. International Journal of Radiation Oncology, Biology, Physics (130)

More Publications

Publishers
  1. American Society of Clinical Oncology (812)
  2. Elsevier Inc. (371)
  3. Springer (359)
  4. American Society of Hematology (302)
  5. American Association for Cancer Research (241)
  6. John Wiley & Sons (219)

More Publishers

Results (3096)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A de novo supernumerary ring chromosome 1 causes B-cell acute lymphoblastic leukemia in monozygotic twins due to independent and partially convergent evolutionary trajectories
    Meeting Abstract

    GutieĢrrez-Abril, J.; Gundem, G.; Fiala, E.; Liosis, K.; Farnoud, N.; Leongamornlert, D.; Amallraja, A.; Ossa, J. E. A.; Domenico, D.; Levine, M. F.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Dietary patterns among individuals with plasma cell disorders compared to the general US population
    Meeting Abstract

    Traore, K.; Taneja, A.; Gorshein, E.; Castro, F.; Derkach, A.; Martinez, J. A. H.; Serrano, E.; Lesokhin, A.; Ahlstrom, J. M.; Block, T.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Bleeding and thrombosis in patients with cancer and acute venous thromboembolism requiring urgent procedures
    Meeting Abstract

    Owusu, T.; Derkach, A.; Burge, M.; Nemirovsky, D.; Zwicker, J. I.
    Blood (2023)

    Fulltext@MSK | Save
  • A phase 2 study of minimal residual disease (MRD)-adapted front line venetoclax and obinutuzumab in fit patients with chronic lymphocytic leukemia (CLL): Effect of obinutuzumab on tumor lysis syndrome (TLS) risk and safety of outpatient venetoclax dose escalation
    Meeting Abstract

    Roeker, L. E.; Zelenetz, A. D.; Park, J. H.; Derkach, A.; Geyer, M. B.; Islam, P.; Falchi, L.; Palomba, M. L.; Kumar, A.; Salles, G.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • A phase I study of ruxolitinib in combination with abemaciclib for patients with primary or post-polycythemia vera/essential thrombocythemia myelofibrosis
    Meeting Abstract

    Bewersdorf, J. P.; Derkach, A.; Masarova, L.; Pemmaraju, N.; Stein, E. M.; Mauro, M.; Rampal, R. K.; Bose, P.
    Blood (2023)

    Fulltext@MSK | Save
  • Responses and outcomes after second-line therapy in transplant-eligible patients with DLBCL relapse over 1 year after first-line therapy
    Meeting Abstract

    Qualls, D. A.; Shah, G. L.; Shouval, R.; Caron, P.; David, K. A.; Falchi, L.; Ghione, P.; Hamlin, P. A.; Horwitz, S. M.; Intlekofer, A. M.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • A phase 1b multi-center study of the FLT3 inhibitor gilteritinib in combination with the IDH1 inhibitor ivosidenib or the IDH2 inhibitor enasidenib for patients with relapsed or refractory acute myeloid leukemia who have co-occurring FLT3/IDH1 or FLT3/IDH2 mutations
    Meeting Abstract

    Stein, E. M.; Derkach, A.; Melamed, G.; Block, A.; Kim, J.; Georgieva, G.; Thompson, V.; Levine, R. L.; Intlekofer, A. M.; Abdel-Wahab, O.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Pilot study of longitudinal geriatric assessment and neurocognitive evaluation in CAR T-cell therapy for older patients with relapsed refractory, large B-cell lymphoma
    Meeting Abstract

    Lin, R. J.; Kim, S. J.; Correa, D.; Elko, T. A.; Lobaugh, S.; Baser, R.; Koch, A.; Hanley, D. M.; Palomba, M. L.; Dahi, P. B.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Daratumumab, bortezomib, lenalidomide, and dexamethasone (DVRd) and daratumumab, carfilzomib, lenalidomide and dexamethasone (DKRd) as induction therapy in newly diagnosed multiple myeloma
    Meeting Abstract

    Tan, C.; Maclachlan, K. H.; Nemirovsky, D.; Derkach, A.; Hultcrantz, M.; Hassoun, H.; Mailankody, S.; Shah, U. A.; Rajeeve, S.; Patel, D.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • T-cell exhaustion signature predicts early relapse after autologous stem cell transplant for multiple myeloma: BMT CTN 0702 secondary immune analysis
    Meeting Abstract

    Mehanna, N.; Derkach, A.; Gasmi, B.; Anagnostou, T.; Landau, H.; Lahoud, O. B.; Scordo, M.; Shah, G. L.; Hassoun, H.; Maclachlan, K. H.; more...
    Blood (2023)

    Fulltext@MSK | Save